Seagen
SGEN
#529
Rank
S$55.69 B
Marketcap
S$295.21
Share price
-0.07%
Change (1 day)
62.30%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -S$1.07 Billion

According to Seagen 's latest financial reports the company's current earnings are S$2.30 Billion. In 2022 the company made an earning of -S$0.8 Billion, an increase over its 2021 earnings that were of -S$0.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$1.07 Billion34.79%
2022 -S$0.8 Billion-10.13%
2021 -S$0.89 Billion-214.28%
2020 S$0.77 B-370.63%
2019 -S$0.29 Billion-15.17%
2018 -S$0.34 Billion32.79%
2017 -S$0.26 Billion37.19%
2016 -S$0.19 Billion18%
2015 -S$0.16 Billion56.34%
2014 -S$99.85 Million23.07%
2013 -S$81.13 Million
2011 -S$0.19 Billion111.72%
2010 -S$88.02 Million-19.63%
2009 -S$0.11 Billion-7.55%
2008 -S$0.12 Billion64.95%
2007 -S$71.82 Million38.4%
2006 -S$51.89 Million25.36%
2005 -S$41.4 Million-14.86%
2004 -S$48.62 Million61.92%
2003 -S$30.03 Million-7.67%
2002 -S$32.52 Million6.76%
2001 -S$30.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.15 B-1,389.19%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$8.51 B-934.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.00 B-296.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.03 B-1,279.90%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.77 B-1,351.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-S$79.87 Million-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-S$81.03 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.38 Billion-63.65%๐Ÿ‡บ๐Ÿ‡ธ USA